Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 34 entries
View as:

Diabetic Retinopathy Classification: ETDRS 7-fields vs Widefield Imaging (ClarusDR)

Phase: N/A Priority: Normal
NCT ID: NCT05746975 Org: User:
Start: 04/03/23 End: 11/04/24 Due: 11/04/25

A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients

Phase: N/A Priority: Normal
NCT ID: NCT02359526 Org: User:
Start: 10/31/14 End: 12/31/16 Due: 12/31/17

Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT01220804 Org: User:
Start: 11/30/10 End: 03/31/13 Due: 03/31/14

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

Phase: N/A Priority: Normal
NCT ID: NCT01281098 Org: User:
Start: 03/31/10 End: 02/28/13 Due: 02/28/14

Retinal Ischemia Characterization in Diabetes - "RICHARD"

Phase: N/A Priority: Normal
NCT ID: NCT05112445 Org: User:
Start: 03/30/22 End: 04/30/25 Due: 04/30/26

Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)

Phase: N/A Priority: Normal
NCT ID: NCT01947881 Org: User:
Start: 01/31/14 End: 10/31/15 Due: 10/31/16

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Phase: N/A Priority: Normal
NCT ID: NCT03696810 Org: User:
Start: 10/30/18 End: 06/29/22 Due: 06/29/23

Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or More

Phase: N/A Priority: Normal
NCT ID: NCT01715870 Org: User:
Start: 12/31/12 End: 04/30/14 Due: 04/30/15

10-year Progression of Diabetic Retinopathy: Identification of Signs and Surrogate Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT04650165 Org: User:
Start: 06/01/21 End: 03/27/24 Due: 03/27/25

Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study

Phase: N/A Priority: Normal
NCT ID: NCT01975714 Org: User:
Start: 10/31/13 End: 02/28/15 Due: 02/28/16

Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)

Phase: N/A Priority: Normal
NCT ID: NCT01440660 Org: User:
Start: 01/31/12 End: 09/30/14 Due: 09/30/15

Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT00797524 Org: User:
Start: 11/30/08 End: 10/31/10 Due: 10/31/11

Characterization of Potential Biomarkers of Eye Disease and Vision

Phase: N/A Priority: Normal
NCT ID: NCT02500862 Org: User:
Start: 09/30/15 End: 12/31/26 Due: 12/31/27

Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT01228981 Org: User:
Start: 03/31/10 End: 03/31/13 Due: 03/31/14

Characterization of Early Markers of Choroidal Neovascularization

Phase: N/A Priority: Normal
NCT ID: NCT00801541 Org: User:
Start: 12/31/05 End: 06/30/14 Due: 06/30/15

Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2

Phase: N/A Priority: Normal
NCT ID: NCT00763802 Org: User:
Start: 09/30/07 End: 05/31/11 Due: 05/31/12

Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT04241536 Org: User:
Start: 06/01/21 End: 11/29/22 Due: 11/29/23

Clinical Evaluation of Noninvasive OCT Angiography Using a Zeiss OCT Prototype to Compare to Fluorescein Angiography

Phase: N/A Priority: Normal
NCT ID: NCT02391558 Org: User:
Start: 09/30/15 End: 04/30/16 Due: 04/30/17

Biomarkers of Diabetic Retinopathy Progression

Phase: N/A Priority: Normal
NCT ID: NCT01607190 Org: User:
Start: 11/30/12 End: 12/31/17 Due: 12/31/18

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

Phase: N/A Priority: Normal
NCT ID: NCT02495181 Org: User:
Start: 11/23/15 End: 12/17/19 Due: 12/17/20

Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function

Phase: N/A Priority: Normal
NCT ID: NCT00759044 Org: User:
Start: 03/31/08 End: 10/31/10 Due: 10/31/11

Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

Phase: N/A Priority: Normal
NCT ID: NCT01298674 Org: User:
Start: 08/31/09 End: 10/31/13 Due: 10/31/14

Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal

Phase: N/A Priority: Normal
NCT ID: NCT02748824 Org: User:
Start: 07/31/16 End: 10/31/17 Due: 10/31/18

Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03010397 Org: User:
Start: 12/31/16 End: 03/06/19 Due: 03/06/20

Retinal Thickness Analysis Using Optical Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT00797134 Org: User:
Start: 11/30/08 End: 07/31/10 Due: 07/31/11